Nomad Power Solutions NMAD
NASDAQ NMAD
$4.12 +0.26 (+6.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Accumulated Expenses (2018)

Updated

Nomad Power Solutions (NMAD) posted Accumulated Expenses of $50,000 for Q3 2018, unchanged from the prior quarter.

Analysis

Nomad Power Solutions (NMAD) Accumulated Expenses (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Nomad Power Solutions 60.44 Mn 61.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 50,000.00
Jun 30, 2018 50,000.00
API Access

Nomad Power Solutions Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NMAD&period=max&api_key=YOUR_API_KEY